delayed release tablets articles & resources on Made-in-China.com

Mylan Announced That Its U.S. Has Launched Mycophenolic Acid Delayed-Release Tablets

Jan 10, 2014

Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Mycophenolic Acid Delayed-release Tablets, 180 mg and 360 mg. This product is the generic version of Novartis' Myfortic® ...

Tags: Mylan, Mycophenolic Acid Delayed-release Tablets

FDA Has Approved Merck's Noxafil 100 Mg Delayed-Release Tablets.

Nov 29, 2013

The US Food and Drug Administration (FDA) has approved Merck's Noxafil (posaconazole) 100 mg delayed-release tablets. The tablets are a new formulation with a loading dose of 300mg (three 100mg delayed-release tablets) twice daily on the ...

Tags: Health, Medicine

LPI Has Launched Its Generic Rabeprazole Sodium Delayed-release Tablets,20mg

Nov 14, 2013

Lupin Pharmaceuticals (LPI), a US subsidiary of India-based Lupin, has launched its generic Rabeprazole Sodium delayed-release tablets, 20mg. Earlier, the company had received final approval from the US Food and Drug Administration (FDA) ...

Tags: Lupin Pharma, tablets

Innopharma Has Introduced Acamprosate Calcium The Generic Version of Campral

Aug 19, 2013

Sterile product development company InnoPharma has introduced acamprosate calcium, 333mg delayed-release tablets, the generic version of Campral. The generic formulation of acamprosate delayed-release tablets was developed by InnoPharma, ...

Tags: Generic Version, Campral

Horizon Pharma Has Commenced The Full Commercial Launch of Rayos Delayed-Release Tablets

Feb 18, 2013

Specialty pharmaceutical company Horizon Pharma has commenced the full commercial launch of Rayos (Prednisone) delayed-release tablets for rheumatology indications, such as rheumatoid arthritis and polymyalgia rheumatica. Rayos is a ...

Tags: Horizon Pharma, Rayos, delayed-release tablets, rheumatology indications

Pharma Announced The Issuance of Additional Notice of Allowance From The US Patent

Feb 13, 2013

Horizon Pharma has announced the issuance of additional notice of allowance from the US Patent and Trademark Office for Rayos (Prednisone) delayed-release tablets. Skyepharma received the notice of allowance for US patent application ...

Tags: Horizon Pharma, Rayos, release tablets

Horizon Pharma Has Commercially Launched Rayos Delayed Release Tablets in The US

Dec 10, 2012

Horizon Pharma has commercially launched Rayos (prednisone) delayed release tablets in the US. Rayos is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma ...

Tags: Horizon Pharma, Rayos, rheumatoid arthritis

Horizon Pharma RAYOS Tabletsreceived FDA Approval

Dec 7, 2012

Horizon Pharma RAYOS (prednisone) delayed-release tablets have received the US Food and Drug Administration (FDA) approval. The approved drug is used to treat rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis ...

Tags: Horizon Pharma RAYOS delayed-release tablets, rheumatoid arthritis, RA

Watson Laboratories Won FDA Abbreviated New Drug Application Approval

Dec 5, 2012

Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has won FDA abbreviated new drug application approval for Diclofenac Sodium and Misoprostol Delayed-Release Tablets. The company plans to launch Diclofenac Sodium and ...

Tags: Watson Laboratories

USPTO Granted NOA to SkyePharma for a Patent Application 2012/0177734

Dec 5, 2012

The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to SkyePharma for a patent application 2012/0177734 of RAYOS (Prednisone) delayed-release tablets. The NOA covers the FDA-approved RAYOS, which uses the ...

Tags: SkyePharma, RAYOS delayed-release tablets, rheumatoid arthritis

delayed release tablets

Related Products